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Abstract 
CD44, a transmembrane glycoprotein receptor for extracellular matrix molecules such as 
hyaluronic acid and osteopontin, is involved in glioma cellular signalling, adhesion and 
invasion. Although a great deal is known concerning the molecular players in adhesion, 
migration and invasion, little is known relating to how these invasive and migratory-
promoting proteins influence biomechanical properties of glioma cells. Herein, we extend 
previous CD44 blocking experiments to examine effects of CD44 knock-down on expression 
of cytoskeletal proteins and cellular stiffness. 
An atomic force microscope (AFM) nanoindentation method was used to measure 
deformation or cellular stiffness (Young's Modulus, E) in real time, at the single cell level 
over nuclear and cytoplasmic regions. A glioblastoma cell line (SNB-19) was transfected 
with either CD44 siRNA, scrambled siRNA, or a non-related gene siRNA. In SNB-19 CD44 
knock-down cells, levels of microtubule, vimentin and GFAP proteins were lower compared 
to cells transfected with scrambled siRNA. Functionally, CD44 knock-down cells were less 
migratory compared to controls. AFM nanoindentation results show that the area over the 
nuclei of both knock-down and parental control cells examined were significantly more 
compliant than their cytoplasmic regions (p < 0.001). The most striking difference was seen 
when comparing nuclear regions of parental control cells versus CD44 knock-down cells. 
CD44 knock-down SNB-19 cells (E = 0.56 ± 0.50 kPa) were less stiff than parental cells (E 
= 1.93 ± 2.86 kPa; p < 0.001). Based on these results we hypothesise that CD44 signalling 
via cytoskeletal proteins such as vimentin may influence the ability of glioma cells to 
respond to host-tumour derived mechanical pressures. 
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1. Introduction 
Glioma cell invasion is strongly influenced by multiple modes of interactions including 
tumour cell/host cell communication and signalling and biophysical properties of both 
tumour cell and extracellular matrix (ECM) [1,2]. The glioma microenvironment is dynamic 
in nature and, in response to therapies, will adapt to survive. While our understanding of 
host/tumour, immune/tumour interactions are improving, the appreciation of how 
biomechanical and biophysical properties contribute to influencing glioma growth and 
invasion is beginning to be recognised [1,3]. Identification of key host/tumour interactions 
and the integration of how mechanical cues drive tumour adaptations could provide 
potential targets involved in therapeutic resistance. Mechanical cues that can potentially 
influence the invasive process include substrate stiffness, fluid shear flow and local and 
global cell strain due to host/tumour changes (i.e., growth, edema). How a glioma cell 
responds to mechanical cues will most likely depend on its genomic, epigenomic, and 
proteomic composition as well as ECM stiffness. It will be important to understand the 
integration of biophysical information during changes associated with glioma growth and 
during therapeutic challenges in terms of understanding adaptive mechanisms [2]. The 
ability of a cell to deform is related to cytoskeletal components, actin, microtubulin, and 
intermediate filaments [4,5]. The degree to which particular cytoskeletal component is more 
important may be dependent on experimental systems [5]. There is a documented 
association of mechanical phenotype with cancer development; however specific 
mechanisms are yet to be agreed upon [4,6,7]. Recent studies on the dynamic 
reorganisation of the cytoskeleton in cancer cells have drawn great interest in 
understanding mechanical properties involved in cancer invasion and metastasis [4,8-10]. 
Changes in such biomechanical properties and cytoskeletal reorganisation have been 
observed in cancer cells of aggressive phenotypes [4,10]. Indeed, it has been suggested 
that the elastic properties (i.e., stiffness) of tissue/cells could be an indication of cancer 
[11,12], and previous studies using different biomechanical assays have revealed a 
correlation between reduced stiffness and increased metastatic potential of human cancer 
cells [13].  
 
CD44 is a transmembrane receptor expressed on glioma cells and is known to be involved in 
cell adhesion, glioma invasion and migration [14-18]. CD44 serves as a cell receptor for 
hyaluronic acid [20,21] and osteopontin [20]. Hyaluronic acid (HA), a glycosaminoglycan 
[21], is a major component of brain ECM and high levels, corresponding to increased 
malignancy, are expressed in tumours [22-24]. HA binds to the surface of GBM cells via 
CD44, a cell adhesion glycoprotein [26], which is essential for the maintenance of the three-
dimensional structure of organs/tissues; CD44 is present in many cells including normal 
astrocytes, but is significantly upregulated in GBM [26]. Recently, it has been reported that 
CD44 expression correlates with short survival in the proneural subtype of GBM [20]. We 
have previously described that inhibition of CD44 expression in glioma cell lines, either by 
antibody blocking or gene silencing (siRNA), produced GBM cells that lacked invadopodia, 
were rounder and less invasive than wild type cells [27]. This effect was mediated in part by 
RhoGTPase signalling [27]. This signalling pathway has been implicated in cellular stiffness 
in U373 glioma cells [28]. In the current paper, we report the effects of CD44 knockdown in 
glioma cell lines with an emphasis on the examination of cytoskeletal protein expression and 
cellular stiffness measured using atomic force microscopy (AFM). This technology allows 
determination of the ability of a cell to deform through the analysis of force vs. 
displacement curves, obtained by placing the AFM probe over the cell and making 
nanoindentations. This measure of deformity or elasticity is known as the elastic modulus or 
Young’s modulus (E) [29,30]. While discovered as a means to examine different types of 
materials, E is classically defined as the ratio of stress (force / area) along an axis to strain 
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(deformation) in which Hooke’s law (restoring force to a spring is proportional to a small 
displacement) holds [31,32]. AFM nanoindentation studies have been performed on a 
variety of cell types to obtain E values, which typically range from 100 Pa (epithelial, 
compliant) [33] to 100 GPa (enamel, stiff) [34]. Such measurements have also been carried 
out on a broad range of cancer cells and tissues, including bladder [35,36], breast [6,37-
40], cervical [41], esophageal [42], liver [43,44], lung [37], ovarian [4,45], pancreas 
[37,46,47], prostate [6,48,49], thyroid [50] and melanoma [10]. In most studies, AFM 
measurements were usually performed by probing specific regions of the cell, such as 
central [37,38,48], above the nucleus [4,6,10,41,42,49], or perinuclear regions [45,49]. 
Typically, cancer cells are less stiff (lower E) compared to their benign counterparts. It has 
been suggested that softer cells are more motile than stiffer cells and this has been linked 
to the ability of malignant cells to invade and metastasise in vivo [4,7,35,37,45]. In this 
paper, we report on the effects of CD44 knock-down in glioma cell lines with an emphasis 
on the examination of specific cytoskeletal protein expression and cellular stiffness (E) 
obtained from AFM measurements. 
 
2. Materials and Methods 
 
2.1 Cells 
 
The established human glioblastoma cell line, SNB-19 (passage-44), was obtained from the 
DSMZ German Brain Tumour Bank (Germany). The cell lines were authenticated using an 
STR-PCR kit, GenePrint 10 (Promega, UK), as per the manufacturer's instruction. The STR 
profile of the cells was compared with the DSMZ database to confirm the identity of the 
SNB-19 cells. Cells are routinely mycoplasma tested utilizing a kit from Lonza, Germany. 
Cell authentication is also routinely checked using a microfluidic electrophoresis system 
incorporating an Agilent 2100 Bioanalyzer (Agilent Technologies, USA) to analyse STR-PCR 
fragments from 10 human genomic loci of human cell lines [51]. CD44 knock-down in SNB-
19 cells was achieved by CD44-targeting SMARTpool® siRNA transfection (Dharmacon, UK), 
following the manufacturer’s instructions [27]. Briefly, SNB-19 cells were incubated with 
CD44-siRNA for 96 h to achieve > 80% knock-down of the target gene and for 120 h in 
morphology assays. An AccellTM non-targeting pool siRNA was included in the knock-down 
experiments as the negative control and GADP-siRNA as the positive control. The GADP-
siRNA also served to optimise and monitor efficiency of siRNA delivery into SNB-19 cells 
[27]. All cells were cultured in Dulbecco’s Modified Eagle Medium (Gibco, UK) with 10% 
foetal calf serum (Sigma, Dorset, UK).  
  
2.2 Antibodies 
Primary antibodies. Mouse monoclonal anti-CD44 (1:500 in immunocytochemistry; 1:25 in 
flow cytometry) was purchased from Chemicon (UK). Mouse monoclonal anti-F-actin (1:200 
and 1:20) from Invitrogen (UK), mouse monoclonal anti-microtubule (1:100 and 1:10) from 
Santa Cruz (USA), rabbit polyclonal anti-GFAP (1:200 and 1:20) and mouse monoclonal 
anti-Vimentin (1:500 and 1:50) both from Dako (UK) were used for immunocytochemistry 
and flow cytometry, respectively. Rabbit polyclonal anti-β-actin (1:1000) (Sigma), rabbit 
polyclonal anti-CD44 (1:250) (Santa Cruz), mouse monoclonal anti-microtubule (1:500) 
(Santa Cruz), rabbit polyclonal anti-GFAP (1:1000) (Dako), mouse monoclonal anti-
Vimentin (1:1000) (Dako) and goat polyclonal anti-GAPDH (1:200) (Abcam) were used for 
Western blotting. 
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Secondary Antibodies. Fluorochrome-conjugated AlexaFluor-488 (Invitrogen) was used in 
flow cytometry and ICC both at dilution 1:500. Horseradish peroxidase (HRP)-conjugated 
IgG (Invitrogen) was used for chemiluminescent detection in Western blotting (1:1000).  
 
2.3 Immunocytochemistry (ICC) 
 
ICC was carried out following an established procedure previously described [27]. Cells were 
fixed with 4% paraformaldehyde (PFA) (Sigma, UK) and permeabilised with 0.2% Triton X-
100 (Sigma, UK) for intracellular antigen detection before incubation with the primary 
antibody. Cells were then incubated with the relevant secondary antibody. Cells were 
washed with 1×PBS before and after each antibody’s incubation. Nuclei were counterstained 
with Hoechst Blue (Sigma, UK) and the slides were viewed using a Zeiss Axio Imager Z1 
fluorescence microscope (Carl Zeiss, Welwyn Garden City, UK). Images were captured using 
Volocity Image Analysis Software (V5.2, Perkin Elmer, Cambridge, UK). 
 
2.4 Flow cytometry 
 
Flow cytometry was performed based on standard protocols [27]. Briefly, cells were 
permeabilised with cytofix/cytoperm solution (BD Biosciences, UK) for intracellular antigen 
staining prior to primary antibody incubation. Cells were then washed with 5% serum/PBS 
and incubated with the corresponding secondary antibody. After the incubation, cells were 
washed and resuspended in 1% serum/PBS then transferred to fluorescence-activated cell 
sorting (FACS) tubes (BD Biosciences) for analysis. Each sample was analysed in triplicate 
plus one negative control where primary antibody was omitted, and the experiment was 
repeated three times. Analysis was performed on a four-colour-multi-parameter FACS 
Calibur (BD Biosciences) and the expression level was assessed by the percentage of 
positive cell population [positive cells (%)], as described previously [28]. 
 
2.5 Western blotting (WB) 
 
Cell lysates were separated in the “any kDa” pre-cast SDS-PAGE gel (Bio-rad Laboratories 
Ltd, UK) and transblotted onto a polyvinylidene difluoride membrane (GE Healthcare Life 
Sciences, UK). Immunodetection was achieved using the primary antibodies and 
horseradish peroxidase-conjugated secondary antibodies. The blot was then visualised and 
analysed with the GBOX Chemi XT16 system (Synoptics). Parental SNB-19 cells and non-
targeting siRNA treated cells were used as controls in various assays (refer to individual 
results and figure legends). For siRNA knock-down experiments, all transfected cells were 
harvested after 96 h siRNA-incubation for lysate extraction. 
 
2.6 Migration assay 
 
Cell migration was assessed through the TranswellTM modified Boyden Chamber assay. Cells 
were grown in serum free media. The TranswellTM inserts used were 8 µm porosity, 
polycarbonate membrane filters within 24-well plates (Corning, UK). Platelet-derived growth 
factor (PDGFAB; 10 ng/ml; Universal Biologicals Cambridge, UK) diluted in serum free media 
(SFM) was used as a chemoattractant and added to the lower chamber of the well. Cells 
were harvested, counted and seeded at a concentration of 1105 cells/100 µl SFM in the 
upper compartment of the TranswellTM unit. Migration was allowed to occur for 6 h at 37 ºC 
in a 5% CO2 chamber. The filters were then removed and fixed in methanol. Non-migrated 
cells on the upper surface of the filter were removed with a cotton swab and migrated cells, 
adherent on the lower filter surface were stained with Diff Quick (BDH Laboratory Supplies, 
UK) and cells were counted in 5 random fields. Each experiment was performed in triplicate. 
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Mean values of migrated cells for each point were calculated. Migration was expressed as 
mean ± SEM of the number of total cells counted per well. 
 
2.7 Confocal microscopy 
 
Confocal microscopy was carried out with a Zeiss LSM 510 Meta Axioskop2 confocal 
microscope (Carl Zeiss), as previously described [27]. Fluorescence was detected using 
excitation wavelengths of 488 nm (green), 568 nm (red) and 405 nm (blue), with an argon, 
HeNe1 and diode laser, respectively. Multi-track image capture was performed with two 
channels so that different colours were imaged by separate channels to prevent any overlap 
in excitation spectra. Identical settings were used to capture images of negative controls 
where primary antibody was omitted. 
 
2.8 AFM elasticity measurements 
 
AFM nanoindentation experiments were carried out using a CellHesion 200 AFM (JPK 
Instruments, Cambridge, UK) mounted on a Zeiss Axiovert 200M (Carl Zeiss) inverted 
optical microscope placed on a Halcyonics Micro 40 anti-vibration table (Accurion, 
Goettingen, Germany). A Petri dish of cells (in growth media, lid removed; glass-bottomed) 
was placed on an integrated Petri dish heater (37 °C; JPK Instruments) and a 20 objective, 
on the inverted microscope, was used to locate cells of interest. In this experimental design, 
only single, isolated cells were investigated to avoid influence from neighbouring cells [48]. 
An ‘arrow-shaped’, tipless cantilever (Arrow-TL1-50; nominal length lnom = 500 µm, knom = 
0.03 N m-1; NanoWorld, Neuchatel, Switzerland) with a pre-attached glass microsphere 
(radius of curvature R = 5.6 µm) was used in all experiments; the use of a single probe was 
considered to reduce errors (ca. 15 – 20%) introduced by cantilever spring constant (k) 
measurement [52]. This property was determined prior to bio-indentation studies using the 
method of Hutter and Bechhoefer (k = 0.02876 N m-1) [53] and obtaining a force vs. 
distance curve on the bottom of the glass Petri dish (in media) in a region devoid of cells. 
The AFM probe was lowered into the medium, positioned above the region of interest and an 
optical microscopy image was obtained for each cell. The probe was then brought into 
contact with the surface using the automated approach. Force vs. distance curves were 
obtained on nuclear and cytoplasmic (off-nuclei) regions (50 cells of each cell type, one 
force curve per region of the cell; N = 50  2). For the latter regions, the AFM probe did not 
‘reach over’ the nuclei and therefore possible undesirable cantilever-nuclei interactions were 
avoided. An approach distance of 50 µm, a force set-point of 10 nN (before releasing the 
applied load) and a tip velocity of 5 µm s-1 were used. Indentation speeds between 3 and 16 
µm s-1 have been shown to result in relatively constant E values [54]. Force curve 
acquisition and data processing was performed using the AFM software (JPK Data Processing 
Software V5.1.13). Force curves (approach cycle) were off-set (baseline) and tilt corrected; 
the contact point (CP) in each curve was estimated by visual inspection (deviation from 
baseline) and heights corrected for cantilever bending (converted to tip-sample separation). 
E values were then obtained by fitting the corrected approach force curves to a Hertzian 
model, which describes the variation of applied load F with indentation  as a sphere (radius 
R; at the end of a parabolic indenter) is pressed into an elastic half-space [55]:  
 
𝐹 =
4√𝑅
3(1−𝜈2)
𝐸𝛿3/2          (1) 
 
where  = Poisson ratio (0.5, assuming cells to be flat, isotropic and incompressible, in 
keeping with most studies on soft biological systems [56]. 
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Indentations initially were restricted to ca. 10% of the cell thickness (nuclear regions), since 
above this range, substrate effects make a large contribution to the apparent stiffness and 
the Hertz model may no longer be applied [54-57]. Thus, cell thickness measurements of 
wild type SNB-19 cells (same media and glass-bottomed petri dish) were obtained from AFM 
line-profiles (NanoWizard 3, JPK Instruments) using an ‘arrow-shaped’ Si cantilever 
(HQ:CSC37/No Al; probe ‘C’, nominal length lnom = 300 ± 5 µm, width wnom = 35 ± 3 µm, 
thickness tnom = 2.0 ± 0.5 µm, spring constant knom = 0.4 N m
-1; Mikromasch Europe, 
Wetzlar, Germany) with integrated tip (R = 8 nm, h = 12 – 18 µm; n = 10). Cell 
thicknesses were 8.2 ± 3.3 and 1.1 ± 0.4 µm for nuclear and cytoplasm, respectively;  
values were restricted to ca. 0.5 µm from the CP, which provided a good Hertzian model fit 
of the force-distance AFM data in the case of nuclear regions. The indentation of ca. 50% of 
cell thickness for cytoplasmic areas yielded more stable Hertzian fit plots, although the 
resultant E values agreed with those obtained at 10% indentation in most cases. Some 
force-curves (< 5%), from all cell types, were rejected during acquisition due to non-
favourable tip-sample interactions (erroneously shaped curves). Differences in E values 
associated with using the spherical indenter model rather than the chosen parabolic 
indenter model, which is sufficient for shallow contacts, were < 10%, and within the error of 
accurately determining k. 
 
Since CD44 siRNA knock-down was only partially complete, a proportion of the cells deemed 
to be knocked down were selected for further analysis. This was carried out by 3 of the 
investigators (ZM, QA and HF) independently examining the phase contrast images of each 
cell taken immediately before AFM data acquisition. This was done in a masked fashion with 
images not identifiable until after examination. Cells were only deemed knocked down when 
there was a 100% consensus of images where the morphology was similar to published 
reports [27]. 
 
2.9 Statistics  
 
Migration and Flow analysis: Statistical analysis was performed using one-way ANOVA 
followed by Tukey’s multiple comparison post-test with a probability  of less than 0.05 
being regarded as significant. The software package GraphPad Prism 3.02 was used to 
calculate the statistical tests where all data are expressed as mean values. 
AFM analysis: E values (independent groups; nuclear and cytoplasm areas) were analysed 
using Q-Q plots and normality tests (Shapiro-Wilks;  = 0.05, two-tailed) were used to 
compare distributions [58]. Homogeneity was tested using a Levene’s test ( = 0.05, two-
tailed) and Student’s t-tests ( = 0.05, two-tailed) used to compare means [58]. All 
statistics were performed using SPSS Statistics 21 (IBM SPSS, NY, USA). 
 
3. Results 
 
Previously, we have shown that blocking CD44 expression in glioma cells resulted in a 
repression of cell invasion and this effect was mediated in part by RhoGTPase signalling 
[27]. In this report, we have extended these studies and examined the downstream effects 
of CD44 knock-down on the expression of cytoskeletal proteins involved in cellular migration 
and cellular stiffness (E). SNB-19 glioma cells transfected with CD44 siRNA contained lower 
CD44 protein levels compared with those transfected with scrambled control siRNA (Fig. 
1a). Functionally, SNB-19 cells transfected with CD44-targeted siRNA were less migratory 
than parental SNB-19 cells (Fig. 1b, p < 0.05).  
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Fig. 1. CD44 knock-down (KD) reduces migratory potential of the SNB-19 cells. (a) Western 
blots of CD44 expression in non-targeting siRNA-, GAPDH-, parental controls and CD44-KD SNB-19 
cells. Decreased expression level of CD44 in CD44-KD cells is demonstrated. Expression of GAPDH is 
also shown. (b) Significantly reduced migratory potential of the SNB-19 cells following CD44-KD was 
observed using the TranswellTM modified Boyden chamber technique, compared to the controls cells. * 
indicates statistical significance (p < 0.05). 
 
 
In agreement with our previous study [27], knock-down of CD44 in SNB-19 cells resulted in 
a dramatic change in cellular morphology (Fig. 2a). In CD44 knock-down cells, the cells 
tended to appear rounder, lose the distinct CD44 positive staining and contain fewer 
processes. F-actin, vimentin, GFAP and microtubule positive staining was less pronounced in 
CD44 knock-down SNB-19 cells compared to control SNB-19 cells. While vimentin positive 
staining was associated with prominent filamentous staining in control cells, vimentin 
staining in CD44 knock-down cells appeared to be more granular and punctuated at focal 
adhesion points near edges of cells (Fig. 2, arrows). GFAP staining in CD44 knock-down 
cells seem to lose most of the central cytoplasmic positive staining.  
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Fig. 2. Expression analyses of cytoskeleton-associated molecules in the SNB-19 cells. (a)  
Cellular morphology and distribution of CD44, F-actin, vimentin, GFAP and microtubules in SNB-19 
cells and CD44-KD SNB-19 cells are illustrated by ICC staining. Antigenic proteins were stained by 
Alexa Fluor 488 (Green) with Hoechst Blue nuclei counterstain (Blue). Arrows mark focal adhesion 
points; 40 objective and scale bar = 10 µm (all images). (b) Representative histogram of the flow 
cytometry analysis that shows a reduced percentage of CD44-expressing population in CD44-KD 
(Blue) SNB-19 cells compared to SNB-19 controls (Green) cells. Negative control (Black) is also shown 
in the graph where primary antibody was omitted. (c & d) Significantly reduced expression levels of 
CD44, F-actin, vimentin, GFAP and microtubules in CD44-KD SNB-19 cells were confirmed by flow 
cytometry, as indicated by percentage of positive cells (c) and mean fluorescence fold (d). Results 
are representative of three independent experiments carried out in triplicate (n = 3). * indicates 
statistical significance (p < 0.05). (e) Western blots of vimentin, GFAP and microtubules in non-
targeting siRNA-, GAPDH-, SNB-19, and CD44-KD SNB-19 cells. Decreased expression levels of 
vimentin, GFAP and microtubules in CD44-KD cells are demonstrated. Expression of β-actin (as 
loading control) is also shown.  
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Fig. 3. AFM elasticity measurements of SNB-19 cells. (a) Phase images showing AFM 
nanoindentation analyses above cytoplasmic and nuclear areas of SNB-19 cells and CD44-KD SNB-19 
cells. Cell types were differentiated by cellular morphology. (b & c) Boxplots showing frequency (b) 
and mean (c) distributions of  ln E  obtained from SNB-19 cells and CD44-KD SNB-19 cells on nuclear 
(nuc) and cytoplasm (cyto) regions (N = 50  4). For both cell types, E values obtained from nuclear 
regions were significantly lower than those from cytoplasmic regions (p < 0.001). Focusing on nuclear 
regions, CD44-KD SNB-19 cells showed significantly lower E values compared to SNB-19 cells (p < 
0.001). 
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Quantitative analysis using flow cytometric analysis demonstrated that the reduction in F-
actin, vimentin, GFAP and microtubule expression in SNB-19 CD44 knock-down cells was 
significant compared with wild type SNB-19 cells (Fig. 2c-d, p < 0.05). Similar results 
demonstrating the reduction in vimentin, GFAP and microtubule expression in CD44 knock-
down cells were seen in Western Blot analysis (Fig. 2e). 
 
We next asked the question if the changes in morphology and reduced cytoskeletal protein 
expression and migration seen in CD44 knock-down SNB-19 cells was associated with a 
difference in mechanical properties, specifically, cell stiffness (E). Prior to the analysis of cell 
stiffness, we needed to insure that the AFM measurements were conducted on cells with 
CD44 knocked down, as siRNA silencing of CD44 in SNB-19 cells did not result in a total 
reduction of CD44 protein (Fig. 1a). Images were taken of every cell in which E values were 
determined (Fig. 3a). For identifying CD44 knock-down cells, three investigators 
independently scored all images in a blinded fashion and where there was 100% agreement 
on morphological changes associated with CD44 knock-down, these values were analysed. E 
values of wild type SNB-19 and SNB-19/CD44 knock-down cells, from nuclear and 
cytoplasmic regions, were extracted from AFM force-distance curves (Fig. 3b). This property 
was found to be log-normally distributed, as observed elsewhere for other types of cancer 
cells [37]; AFM nanoindentation results show the area over the nucleus of cell lines 
examined were significantly more compliant (pliable) than their cytoplasmic regions (Fig. 
3c, p < 0.001). The most striking difference was seen when comparing nuclear regions of 
parental cells to those of CD44 knock-down cells. CD44 knock-down SNB-19 cells (E = 0.56 
± 0.50 kPa) were less stiff than wild type cells (E = 1.93 ± 2.86 kPa; p < 0.001). 
 
 
4. Discussion  
In this report, we have extended our studies exploring potential mechanisms involved in 
CD44-mediated glioma cell invasion by investigating changes in cytoskeletal proteins and 
biomechanical properties associated with inhibition of CD44 expression. Cell invasion 
involves the coordinated integration of many signals and while much is known concerning 
the role of specific genes and proteins and their associated signalling pathways, little is 
known on the influence of biophysical processes that may contribute to glioma invasion. 
These are important to consider as increased cell invasion is likely to include the ability of 
the cell to resist deformation and increase the rate of cytoskeletal dynamics [4,5]. This is 
not a novel concept as Herpers et al., in the mid-1980s, suggested that glioma cells are able 
to adapt to the microenvironment via changes in the cytoskeleton [59]. In this paper, we 
demonstrate that by knocking down CD44 expression in a glioma cell line (SNB-19) there is 
an associated decreased expression of the intermediate filament proteins, vimentin and 
GFAP and of microtubules. Cell migration was decreased in CD44 knock-down cells in 
agreement with published reports that show that inhibition of CD44 expression in glioma 
cells result in a decrease in glioma invasion [27]. We hypothesised that by knocking down 
CD44 and there would be an associated change in glioma cell deformity; specifically, that 
the CD44 knock-down cells would become less pliable (more stiff and increased E values). 
Much of the published information concerning this area assumes that, in general, E values of 
invasive cancer cells are lower (more pliable) than their normal cell counterparts [13]. In 
other words, the effect on reduced migration could be due, in part, to a change in 
mechanical stiffness and that by increasing cellular stiffness, invasion would be decreased. 
However, our results showed that CD44 knock-down glioma cells were less stiff than control 
cells. This difference was only seen in the area over the nucleus as there was no difference 
in cellular stiffness when AFM nanoindentation measurements were conducted away from 
the nucleus. Recently, Rathje et al. [60] reported that cellular stiffness was associated with 
BioNanoScience 
First online: 26 December 2015, pp. 1-11, doi: 10.1007/s12668-015-0189-2 
www.link.springer.com/article/10.1007/s/12668-015-0189-2 
 
11 
 
the reorganisation of vimentin. Interestingly, vimentin is known to be perinuclear and its 
network extends throughout the cell during migration [61]. Rathje et al. showed that 
oncogenes can induce vimentin filament collapse and this is mediated by Histone 
deacetylase 6 (HDAC6), an enzyme responsible for deacetylation of histones resulting in 
condensed chromatin [60]. In our current work, one of the most apparent changes among 
the cytoskeletal proteins examined was seen in vimentin expression and its cellular 
distribution. We have previously shown that the functional effects of inhibiting CD44 are 
mediated, in part, by RhoGTPase signalling [27]. Transfection of U373 glioma cells with a 
constitutively active RhoGTPase resulted in an increase cellular stiffness, as measured by 
AFM nanoindentation [28]. We propose that in our experimental design, knockdown of CD44 
leads to a decrease in vimentin and that the decrease in stiffness around the nucleus is in 
part due to the re-organisation of vimentin (Fig. 4). There is evidence that supports the idea 
that the nucleus can serve as a mechanosensor of external and internal forces [62, 63] and 
the tethering of chromatin to the nuclear envelope can affect nuclear stiffness [64]. Lamin 
proteins are key players that help connect chromatin and the cytoskeleton [65-67], and 
levels of lamin protein expression have been shown to influence cell migration and cell 
viability [67]. The role of the lamin proteins in mechanotransduction and nuclear function is 
a very exciting area of research and information from these investigations will provide much 
needed knowledge into the regulation of gene expression due to biomechanical and 
microenviornmental stresses in GBM. 
 
 
Fig. 4. Simplified model of the effect of CD44-KD on nuclear stiffness. Schematic diagram of 
our working model depicting a decrease in E values caused by the reduced amounts and the re-
organisation of perinuclear vimentin in CD44-KD SNB-19 cells (b) (E2, more compliant) compared with 
SNB-19 control cells (a) (E1). 
 
 
As evidence increases as to the importance of a dynamic tumour microenvironment, the 
incorporation of mechanical properties and how tumour and host cells respond to external 
forces will be critical for a better understanding of host/tumour interactions. The 
cytoskeletal proteins allow the cell to adapt to microenvironmental changes. While cell 
deformation characteristics are determined by cytoskeletal dynamics [5], consideration of 
the factors that influence nanomechanical properties should be considered when making 
comparisons of observed E values between studies. The cellular thickness, depth and 
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duration of indentation, as well as the loading rate, can all affect E values [6]. While there 
are many studies on different types of cancers that report that cancer cells are less stiff 
than less aggressive or non-neoplastic control cells, currently the strongest comparison that 
holds that cancer cells are less stiff than cells of same origin are in ovarian and bladder 
cancers [71]. Although our data demonstrate a decrease in glioma cell stiffness in less 
invasive cells, comparing the same isogenic cell line except for knocking down CD44, the 
general statement ‘more aggressive, invasive cells are less stiff’ probably does not hold true 
for all cancer cell types and is likely to be dependent on context and will vary depending on 
microenvironmental stresses. These issues should be considered for future studies on 
investigating the influence of biomechanical properties on glioma host/tumour interactions 
and glioma cell invasion. 
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